Back to Insider Trading View Full Company Profile

SOPH

SOPHiA GENETICS SA

CIK: 0001840706

Sell (90% confidence)

Last activity: 2 days ago

Insider Roster (9 total, 9 active)

Insider Buys Sells Net Value Holdings
Camblong Jurgi
Chief Executive Officer
0 3 -$46K
3,728,950 shares
$18.13M
Muken Ross
President
0 3 -$30K
698,097 shares
$3.40M
Van Well Daan
Chief Legal Officer
0 3 -$28K
353,669 shares
$1.72M
Xu Zhenyu
Chief Scientific Officer
0 3 -$28K
644,952 shares
$3.14M
Menu Philippe
Chief Medical Officer
0 3 -$28K
281,452 shares
$1.37M
CARDOZA GEORGE
Chief Financial Officer
0 3 -$28K
292,861 shares
$1.43M
Valente Manuela
Chief People Officer
0 3 -$26K
219,275 shares
$1.07M
Verma Abhimanyu
Chief Technology Officer
0 2 -$17K
204,400 shares
$995K
Puylaert Kevin
Chief Sales Officer
0 5 -$3K
148,306 shares
$721K

Recent Transactions

SELL Camblong Jurgi (Chief Executive Officer)

2,500 shares @ $4.86

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Muken Ross (President)

2,424 shares @ $4.87

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL CARDOZA GEORGE (Chief Financial Officer)

2,413 shares @ $4.88

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Van Well Daan (Chief Legal Officer)

2,400 shares @ $4.87

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Xu Zhenyu (Chief Scientific Officer)

2,400 shares @ $4.87

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Menu Philippe (Chief Medical Officer)

2,400 shares @ $4.87

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Valente Manuela (Chief People Officer)

2,376 shares @ $4.87

$12K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Verma Abhimanyu (Chief Technology Officer)

1,030 shares @ $4.87

$5K

Apr 7, 2026

Conviction: | View SEC Filing →
SELL Van Well Daan (Chief Legal Officer)

2,705 shares @ $4.86

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Xu Zhenyu (Chief Scientific Officer)

2,700 shares @ $4.85

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Menu Philippe (Chief Medical Officer)

2,700 shares @ $4.85

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Camblong Jurgi (Chief Executive Officer)

2,600 shares @ $4.85

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Muken Ross (President)

2,600 shares @ $4.85

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Valente Manuela (Chief People Officer)

2,597 shares @ $4.85

$13K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Verma Abhimanyu (Chief Technology Officer)

2,519 shares @ $4.86

$12K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL CARDOZA GEORGE (Chief Financial Officer)

2,520 shares @ $4.85

$12K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Puylaert Kevin (Chief Sales Officer)

548 shares @ $4.86

$3K

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Puylaert Kevin (Chief Sales Officer)

46 shares @ $4.86

$224

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Puylaert Kevin (Chief Sales Officer)

30 shares @ $4.83

$145

Apr 6, 2026

Conviction: | View SEC Filing →
SELL Puylaert Kevin (Chief Sales Officer)

3 shares @ $4.71

$14

Mar 31, 2026

Conviction: | View SEC Filing →
SELL Camblong Jurgi (Chief Executive Officer)

4,486 shares @ $4.77

$21K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Muken Ross (President)

1,183 shares @ $4.79

$6K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL CARDOZA GEORGE (Chief Financial Officer)

774 shares @ $4.79

$4K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Van Well Daan (Chief Legal Officer)

684 shares @ $4.79

$3K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Menu Philippe (Chief Medical Officer)

608 shares @ $4.79

$3K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Xu Zhenyu (Chief Scientific Officer)

608 shares @ $4.78

$3K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Valente Manuela (Chief People Officer)

380 shares @ $4.79

$2K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL Puylaert Kevin (Chief Sales Officer)

33 shares @ $4.76

$157

Mar 19, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.